Article
Gene Editing Applications as Future Cardiovascular Therapies
16 Jul 2025
Abstract excerpt
Cardiovascular disease is the leading cause of global morbidity and mortality, despite advances in pharmacological and surgical interventions. The emergence of CRISPR-Cas9 genome editing technology offers promising approaches for correcting genetic causes of hereditary cardiovascular disorders and modulating pathogenic signaling pathways implicated in various heart diseases. However, several challenges with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
